Randomised controlled trial (RCT)
The gold-standard trial design, where participants are randomly assigned to treatment or control groups.
What it is
A randomised controlled trial (RCT) is a way scientists test whether a new treatment or medicine is safe and effective. In an RCT, participants are randomly assigned to either a group that receives the new treatment or a group that receives a standard or 'control' treatment. This helps scientists compare the two groups and see if the new treatment really works.
How it works
In an RCT, participants are randomly assigned to either the treatment group or the control group. This random assignment helps ensure that the two groups are similar in terms of age, health, and other factors. The treatment group receives the new treatment, while the control group receives the standard treatment. Researchers then compare the outcomes of the two groups to see if the new treatment is effective.
Why it matters
Understanding RCTs is important because they help scientists figure out whether a new treatment is safe and effective for people with cancer. This information can help doctors make informed decisions about the best treatments for their patients. By knowing the results of RCTs, patients and their families can make more informed decisions about their care.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional for guidance on your health.